Literature DB >> 19117248

Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study.

H Laustrup1, A Voss, A Green, P Junker.   

Abstract

OBJECTIVES: To determine the prevalence and annual incidence of definite systemic lupus erythematosus (D-SLE) and incomplete SLE (I-SLE) in a community-based lupus cohort of predominantly Nordic ancestry in an 8-year prospective study from 1995 to 2003, and also to calculate the annual transition rate of I-SLE to D-SLE.
METHODS: In 1995 all SLE patients in the county of Funen were retrieved from four separate and independent sources. Incident cases were subsequently identified by surveillance of these sources.
RESULTS: During the 8-year study period the median annual incidence of D-SLE (1.04 per 100 000) and I-SLE (0.36 per 100 000) remained almost constant. The point prevalence (PP) of D-SLE increased from 21.9 to 28.3 per 100 000, and from 6.19 to 7.53 per 100 000 for I-SLE. During follow-up, seven I-SLE patients transformed into D-SLE at a progression rate of 3.64 per 100 person-years at risk [95% confidence interval (CI) 1.44-7.55].
CONCLUSIONS: Denmark is a low-incidence lupus area but lupus prevalence is increasing slowly. I-SLE is a disease variant that may eventually convert into D-SLE.

Entities:  

Mesh:

Year:  2009        PMID: 19117248     DOI: 10.1080/03009740802419073

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  13 in total

1.  Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.

Authors:  Sudumpai Jarukitsopa; Deana D Hoganson; Cynthia S Crowson; Olayemi Sokumbi; Mark D Davis; Clement J Michet; Eric L Matteson; Hilal Maradit Kremers; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

2.  Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.

Authors:  P Elfving; O Marjoniemi; H Niinisalo; A Kononoff; L Arstila; E Savolainen; J Rutanen; O Kaipiainen-Seppänen
Journal:  Rheumatol Int       Date:  2016-04-06       Impact factor: 2.631

Review 3.  Preclinical lupus.

Authors:  Rebecka Bourn; Judith A James
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

Review 4.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

5.  Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.

Authors:  Teresa Aberle; Rebecka L Bourn; Melissa E Munroe; Hua Chen; Virginia C Roberts; Joel M Guthridge; Krista Bean; Julie M Robertson; Kathy L Sivils; Astrid Rasmussen; Meghan Liles; Joan T Merrill; John B Harley; Nancy J Olsen; David R Karp; Judith A James
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

6.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

7.  Organ damage in high-risk patients with systemic and incomplete lupus syndromes.

Authors:  Nancy J Olsen; Maha Yousif; Azza Mutwally; Melinda Cory; Nada Elmagboul; David R Karp
Journal:  Rheumatol Int       Date:  2013-05-30       Impact factor: 2.631

8.  Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.

Authors:  Francis Fatoye; Tadesse Gebrye; Lawrence W Svenson
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

9.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

10.  Autoantibody profiling to follow evolution of lupus syndromes.

Authors:  Nancy J Olsen; Quan-Zhen Li; Jiexia Quan; Ling Wang; Azza Mutwally; David R Karp
Journal:  Arthritis Res Ther       Date:  2012-07-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.